KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Oct 24, 2025 - 3:59PM >>  ABB India 5192.3  [ 0.13% ]  ACC 1844  [ -0.67% ]  Ambuja Cements 560.15  [ -0.77% ]  Asian Paints Ltd. 2491.3  [ -0.42% ]  Axis Bank Ltd. 1247.5  [ -0.94% ]  Bajaj Auto 9038  [ -0.02% ]  Bank of Baroda 266  [ -0.28% ]  Bharti Airtel 2025.55  [ 0.86% ]  Bharat Heavy Ele 235.1  [ 0.38% ]  Bharat Petroleum 333.95  [ 0.85% ]  Britannia Ind. 6015.2  [ -0.82% ]  Cipla 1601.35  [ -2.67% ]  Coal India 394.2  [ 0.43% ]  Colgate Palm 2213  [ -3.31% ]  Dabur India 502.85  [ -1.61% ]  DLF Ltd. 772.75  [ -0.17% ]  Dr. Reddy's Labs 1278.35  [ -0.12% ]  GAIL (India) 180.45  [ 0.28% ]  Grasim Inds. 2832.2  [ -1.10% ]  HCL Technologies 1524.45  [ 0.03% ]  HDFC Bank 1000.05  [ -0.88% ]  Hero MotoCorp 5533.55  [ -0.95% ]  Hindustan Unilever L 2510.25  [ -3.48% ]  Hindalco Indus. 817.4  [ 3.14% ]  ICICI Bank 1375.6  [ 0.89% ]  Indian Hotels Co 735.5  [ -0.25% ]  IndusInd Bank 752.65  [ -0.98% ]  Infosys L 1526.2  [ -0.17% ]  ITC Ltd. 414.75  [ -0.26% ]  Jindal Steel 1015.3  [ 0.62% ]  Kotak Mahindra Bank 2172.1  [ -2.38% ]  L&T 3925.45  [ 0.19% ]  Lupin Ltd. 1933.2  [ -0.35% ]  Mahi. & Mahi 3637.25  [ 0.40% ]  Maruti Suzuki India 16289  [ -0.58% ]  MTNL 42.15  [ 0.07% ]  Nestle India 1271.45  [ -0.16% ]  NIIT Ltd. 106.7  [ -1.39% ]  NMDC Ltd. 74.73  [ 0.73% ]  NTPC 341.35  [ -0.36% ]  ONGC 256.9  [ 1.78% ]  Punj. NationlBak 117.6  [ -0.42% ]  Power Grid Corpo 289.25  [ -0.14% ]  Reliance Inds. 1454.6  [ 0.45% ]  SBI 904.1  [ -0.81% ]  Vedanta 494.8  [ 2.47% ]  Shipping Corpn. 263  [ 5.12% ]  Sun Pharma. 1694.9  [ 0.35% ]  Tata Chemicals 899.55  [ -0.54% ]  Tata Consumer Produc 1149.8  [ -1.05% ]  Tata Motors Passenge 404.75  [ -0.27% ]  Tata Steel 174.9  [ 0.46% ]  Tata Power Co. 397.75  [ 0.06% ]  Tata Consultancy 3087.3  [ 0.41% ]  Tech Mahindra 1461.25  [ -0.11% ]  UltraTech Cement 11936.65  [ -1.70% ]  United Spirits 1353.3  [ 0.19% ]  Wipro 244.7  [ 0.12% ]  Zee Entertainment En 105.2  [ -0.52% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

DIPNA PHARMACHEM LTD.

24 October 2025 | 04:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE0MC401013 BSE Code / NSE Code 543594 / DPL Book Value (Rs.) 15.60 Face Value 10.00
Bookclosure 27/08/2024 52Week High 26 EPS 0.41 P/E 49.90
Market Cap. 48.60 Cr. 52Week Low 6 P/BV / Div Yield (%) 1.30 / 0.00 Market Lot 3,000.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2025-03 

21.3 Provision of Income Tax is made as per the Income Tax Act, 1961.

21.4 The Company have not any such transaction which is not recorded in the books of accounts
that has been surrendered or disclosed as income during the year in the tax assessments
under the Income Tax Act, 1961 such as, search or survey or any other relevant provisions of
the Income Tax Act, 1961).

21.5 The company does not fall under requirements to fulfil given under section 135 corporate
social responsibility.

21.6 The Company have not traded or invested in Crypto currency or Virtual Currency during the
financial year.

21.8 There are no Immovable property held as at the end of current year.

21.9 The company have not made any revaluation in its Property, Plant and Equipment by
registered valuer.

21.10 Loans and advances in the nature of loans are granted to promoters, directors, KMPs and the
related parties (as defined under Companies Act, 2013,) either severally or jointly with any
other person, that are:

21.12 The Company does not have any benami property held in its name. No proceedings have been
initiated on or are pending against the Company for holding benami property under the
Benami Transactions (Prohibition) Act, 1988 (45 of 1988) and Rules made thereunder.

21.13 With regards to the Working Capital Loan,

21.13.1 Working Capital Loans from Banks of Rs.6.19 Crore (Previous Year Rs. 6.34 Crore) are secured
by hypothecation of present and future stock of raw materials, work-in-progress, finished
goods, stores and spares, book debts, outstanding monies, receivables, claims, bills, materials
in transit, etc.

21.13.2 The Company has satisfied all the covenants prescribed in terms of borrowings.

21.14 The Company is not being declared wilful defaulter by any bank or financial institution or other
lender.

21.15 The Company do not have any transactions with companies struck off.

21.16 The Company do not have any charges or satisfaction which is yet to be registered with ROC
beyond the statutory period,

21.17 The Company does not have any layers prescribed under clause (87) of Section 2 of the Act,
read with Companies (Restriction on number of Layers) Rules, 2017.

21.18 Wherever, evidences / supporting for expenditure incurred by the Assessee are not available,
we have relied upon the Vouchers / Statements duly certified by the Directors.

21.19 It is not possible for us to verify whether the payment and receipt in excess of Rs. 200000/-
have been made otherwise then by crossed cheque or bank draft as the necessary evidence is
not in possession of the Assessee. Payment in excess of aforesaid if any, make to Government
Authority or bank is not reported.

21.20 It is not possible for us to verify whether the expenses paid in excess of Rs 10000/- have been
made otherwise then by crossed cheque or bank draft as the necessary evidence is not in
possession of the Assessee. Payment in excess of aforesaid if any, made to Government
Authority or bank is not reported.

21.21 It is not possible for us to verify whether the amount paid for assets in excess of Rs 10000/-
have been made otherwise then by crossed cheque or bank draft as the necessary evidence is
not in possession of the Assessee. Payment in excess of aforesaid if any, made to Government
Authority or bank is not reported.

21.22 In the opinion of the management, current assets, loans & advances are approximately of the
values stated, if realized in the ordinary course of business. Balances of balance sheets like
debtors, creditors, loans, advances etc. including squired up accounts are subject to
confirmation and hence subject to adjustment, if any arising out of reconciliation. Inventories
are taken, as valued and certified by the Assessee or management.

Reasons for Variances Notes:

1. Change is due to significant increase in Principal Payment of Loan.

2. Change is due to significant decrease of Purchase as compared to Previous Year.

3. Change is due to significant increase in Trade Receivable as compared to Previous Year.

4. Change is due to significant decrease of Purchase as compared to Previous Year.

21.24 The Company has no scheme of arrangements approved by the competent authority as per
Companies Act, 2013.

21.25 The Company has not received full information from the suppliers regarding their status under
the Micro, Small & Medium Enterprises Development Act, 2006. Hence, disclosure, if any,
relating to amount unpaid as at the balance sheet date together with interest paid or payable
as per the requirement under the said Act have not been made, compiled & disclosed.

21.26 Previous year figures are regrouped - rearranged wherever it required making them
comparable with the current year figures.

21.27 The Company does not have any relationship with struck off companies as on the balance
sheet date, and hence disclosure is not required for the relationship with struck off companies.

21.28 Deferred Tax:

The breakup of net deferred tax liability as at 31st March, 2025 is as under:

21.29 Utilisation of borrowed funds and share premium

21.29.1 The Company have not advanced or loaned or invested funds to any other person(s) or
entity(ies), including foreign entities (Intermediaries) with the understanding that the
Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the company (Ultimate Beneficiaries) or,

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

21.29.2 The Company has not received any fund from any person(s) or entity(ies), including foreign
entities (Funding Party) with the understanding (whether recorded in writing or otherwise)
that the Company shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the company (Ultimate Beneficiaries) or,

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

21.30 Related Parties Disclosures:

As per the Accounting Standard 18, disclosures of transactions with related parties (As
identified by the Management), as defined in Accounting Standard are given below:


Note: (a) The remuneration to the key managerial personnel does not include the provisions made for

gratuity, as it is determined on an actuarial basis for the company as a whole.

Terms and conditions of transactions with related parties

Outstanding balances at the year-end are unsecured and interest free and settlement occurs in cash.
There have been no guarantees provided or received for any related party receivables or payables.
For the year ended March 31, 2025, the Group has not recorded any impairment of receivables
relating to amounts owned by related parties. This assessment is undertaken at each financial year
through examining the financial position of the related party and the market in which the related party
operates.

For, DEVADIYA & ASSOCIATES For, DIPNA PHARMACHEM LIMITED

Chartered Accountants

CA Sanjay Devadiya

Partner Keyur Shah Dipna Shah

M. No. 112495 Managing Director Director

FRN 123045W DIN: 03167258 DIN: 02507462

UDIN: 25112495BMKTST5463

Keyur Shah

Date: 07/07/2025 Chief Financial Officer

Place: Ahmedabad